WTO GM Biotech: panel decision
One deadline out of the way, am catching up with the WTO world.
Having seen the Shrimp/Turtle decision as a possible basis for a human rights based interpretation of TRIPS, consistent with both article 7 and 8 TRIPS and our project aims, I was disappointed with the panel decision in Biotech. The length of the decision has defeated my printer, so the pleasure of a full read awaits me. Thanks, therefore, to "trade-environment" for their excellent collection of resources. I found particularly helpful Currie's analysis for Greenpeace and Genewatch's letter to Peter Mandelson regarding an appeal.
The panel has adopted a very narrow approach to interpreting and applying WTO agreements, and chosen to take little account of other international agreements. Further international fragmentation, and a trade focussed approach of the WTO DSS seems to beckon.
Having seen the Shrimp/Turtle decision as a possible basis for a human rights based interpretation of TRIPS, consistent with both article 7 and 8 TRIPS and our project aims, I was disappointed with the panel decision in Biotech. The length of the decision has defeated my printer, so the pleasure of a full read awaits me. Thanks, therefore, to "trade-environment" for their excellent collection of resources. I found particularly helpful Currie's analysis for Greenpeace and Genewatch's letter to Peter Mandelson regarding an appeal.
The panel has adopted a very narrow approach to interpreting and applying WTO agreements, and chosen to take little account of other international agreements. Further international fragmentation, and a trade focussed approach of the WTO DSS seems to beckon.
posted by Dr Abbe Brown at 9:54 am
0 Comments:
Post a Comment
<< Home